dbo:abstract |
Die BB Biotech AG ist eine Schweizer Biotechnologie-Investmentgesellschaft. (de) BB Biotech AG is a Swiss investment company in the field of biotechnology. Since 1993 it is listed on the SIX Swiss Exchange, since 1997 on the German TecDAX and since 2000 on the Italian Borsa Italiana. The company invests mainly in the United States and Western Europe. BB Biotech is managed by Bellevue Asset Management, a division of Bellevue Group and accounts for approximately 40% of the Group's Assets Under Management. (en) BB Biotech (SIX : BIO) est une entreprise suisse qui faisait partie de l'indice TecDAX. BB Biotech est une société de portefeuille spécialisée dans la prise de participations dans des sociétés de biotechnologies. (fr) BB Biotech è una delle più grandi società di investimento nel campo delle biotecnologie del mondo. La società è quotata sul listino di Borsa Italiana dove è presente nell'indice FTSE Italia STAR. (it) |
dbo:assets |
4.357E9 |
dbo:foundingDate |
1993-11-09 (xsd:date) |
dbo:foundingYear |
1993-01-01 (xsd:gYear) |
dbo:industry |
dbr:Investment_company |
dbo:keyPerson |
dbr:Chairman |
dbo:location |
dbr:Schaffhausen dbr:Switzerland |
dbo:netIncome |
6.91E8 |
dbo:product |
dbr:Investment_company dbr:Biotechnology |
dbo:thumbnail |
wiki-commons:Special:FilePath/BB_Biotech.svg?width=300 |
dbo:type |
dbr:Aktiengesellschaft |
dbo:wikiPageExternalLink |
http://www.bbbiotech.ch |
dbo:wikiPageID |
21969441 (xsd:integer) |
dbo:wikiPageLength |
11794 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID |
1121426103 (xsd:integer) |
dbo:wikiPageWikiLink |
dbr:Cardiovascular_diseases dbr:Schaffhausen dbr:Net_asset_value dbr:Borsa_Italiana dbr:Vertex_Pharmaceuticals dbr:Investment_company dbr:SIX_Swiss_Exchange dbr:Gene_therapy dbr:RNA_therapeutics dbr:Moderna dbr:Closed-end_fund dbr:Fundamental_analysis dbr:Performance_attribution dbr:Total_shareholder_return dbr:BB_Healthcare_Trust dbr:Health_technology dbr:Hedge_fund dbr:Long/short_equity dbr:Agios_Pharmaceuticals dbr:Alnylam_Pharmaceuticals dbr:Aktiengesellschaft dbr:Financial_risk_management dbr:Cell_therapy dbr:TecDAX dbr:Investment_management dbr:Ionis_Pharmaceuticals dbr:Assets_Under_Management dbc:Companies_listed_on_the_SIX_Swiss_Exchange dbr:Chairman dbr:Biotechnology dbr:Switzerland dbr:Dividend dbr:Autoimmune_disease dbc:Investment_management_companies_of_Switzerland dbc:Investment_companies_of_Switzerland dbr:Financial_instrument dbr:Inborn_errors_of_metabolism dbr:Income_statement dbr:Incyte dbr:Infection dbr:Nasdaq dbr:Neurocrine_Biosciences dbr:Oncology dbr:Market_capitalization dbr:Stock_market_index dbr:Argenx |
dbp:assets |
4.357E9 |
dbp:foundation |
1993-11-09 (xsd:date) |
dbp:homepage |
http://www.bbbiotech.ch |
dbp:industry |
Investments (en) |
dbp:keyPeople |
Erich Hunziker (en) |
dbp:location |
dbr:Schaffhausen dbr:Switzerland |
dbp:logo |
BB Biotech.svg (en) |
dbp:logoSize |
235 (xsd:integer) |
dbp:name |
BB Biotech AG (en) |
dbp:netIncome |
6.91E8 |
dbp:products |
Investment in biotechnology companies (en) |
dbp:tradedAs |
FWB:BBZAEuronext:BIO.MI (en) |
dbp:type |
dbr:Aktiengesellschaft |
dbp:wikiPageUsesTemplate |
dbt:Authority_control dbt:Br dbt:Infobox_company dbt:Reflist dbt:Start_date dbt:Profit dbt:SWX dbt:Switzerland-company-stub |
dcterms:subject |
dbc:Companies_listed_on_the_SIX_Swiss_Exchange dbc:Investment_management_companies_of_Switzerland dbc:Investment_companies_of_Switzerland |
gold:hypernym |
dbr:Company |
schema:sameAs |
http://viaf.org/viaf/135787447 |
rdf:type |
owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatBiotechnologyCompanies yago:WikicatCompaniesEstablishedIn1993 yago:WikicatCompaniesListedOnTheBorsaItaliana yago:WikicatCompaniesListedOnTheFrankfurtStockExchange yago:Abstraction100002137 yago:Company108058098 yago:FinancialInstitution108054721 yago:Group100031264 yago:Institution108053576 yago:InvestmentCompany108070850 yago:NondepositoryFinancialInstitution108419984 yago:Organization108008335 yago:WikicatInformationTechnologyCompaniesOfSwitzerland yago:WikicatInvestmentCompaniesOfSwitzerland yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920 |
rdfs:comment |
Die BB Biotech AG ist eine Schweizer Biotechnologie-Investmentgesellschaft. (de) BB Biotech AG is a Swiss investment company in the field of biotechnology. Since 1993 it is listed on the SIX Swiss Exchange, since 1997 on the German TecDAX and since 2000 on the Italian Borsa Italiana. The company invests mainly in the United States and Western Europe. BB Biotech is managed by Bellevue Asset Management, a division of Bellevue Group and accounts for approximately 40% of the Group's Assets Under Management. (en) BB Biotech (SIX : BIO) est une entreprise suisse qui faisait partie de l'indice TecDAX. BB Biotech est une société de portefeuille spécialisée dans la prise de participations dans des sociétés de biotechnologies. (fr) BB Biotech è una delle più grandi società di investimento nel campo delle biotecnologie del mondo. La società è quotata sul listino di Borsa Italiana dove è presente nell'indice FTSE Italia STAR. (it) |
rdfs:label |
BB Biotech (de) BB Biotech (en) BB Biotech (fr) BB Biotech (it) |
owl:sameAs |
freebase:BB Biotech http://viaf.org/viaf/135787447 yago-res:BB Biotech http://d-nb.info/gnd/10014374-X wikidata:BB Biotech dbpedia-de:BB Biotech dbpedia-fa:BB Biotech dbpedia-fr:BB Biotech dbpedia-it:BB Biotech https://global.dbpedia.org/id/4qbY4 |
prov:wasDerivedFrom |
wikipedia-en:BB_Biotech?oldid=1121426103&ns=0 |
foaf:depiction |
wiki-commons:Special:FilePath/BB_Biotech.svg |
foaf:homepage |
http://www.bbbiotech.ch |
foaf:isPrimaryTopicOf |
wikipedia-en:BB_Biotech |
foaf:name |
BB Biotech AG (en) |
is dbo:wikiPageRedirects of |
dbr:BB_Biotech_AG |
is dbo:wikiPageWikiLink of |
dbr:List_of_companies_of_Switzerland dbr:Mads_Krogsgaard_Thomsen dbr:Ernst_Thomke dbr:BB_Biotech_AG |
is foaf:primaryTopic of |
wikipedia-en:BB_Biotech |